FDA oversight of laboratory-developed tests will facilitate adoption of pharmacogenetic testing into routine clinical care

Hillebrenner E.; Litwack E.; Bradley P.; Donigan K.; Lowe T.; Serrano K.; Kelm K.; Mansfield E.; Gutierrez A.

首页> 外文期刊>The Journal of Clinical Pharmacology: Official Journal of the American College of Clinical Pharmacology >FDA oversight of laboratory-developed tests will facilitate adoption of pharmacogenetic testing into routine clinical care

【24h】

FDA oversight of laboratory-developed tests will facilitate adoption of pharmacogenetic testing into routine clinical care

机译：FDA对实验室开发的测试的监督将促进药物遗传学测试在常规临床护理中的采用

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《The Journal of Clinical Pharmacology: Official Journal of the American College of Clinical Pharmacology 》 |2015年第7期| 共3页
作者
Hillebrenner E.; Litwack E.; Bradley P.; Donigan K.; Lowe T.; Serrano K.; Kelm K.; Mansfield E.; Gutierrez A.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药理学 ;
关键词

相似文献

外文文献
中文文献
专利

1. FDA oversight of laboratory-developed tests will facilitate adoption of pharmacogenetic testing into routine clinical care [J] . Hillebrenner E., Litwack E., Bradley P., The Journal of Clinical Pharmacology: Official Journal of the American College of Clinical Pharmacology . 2015 ,第7期

机译：FDA对实验室开发的测试的监督将促进药物遗传学测试在常规临床护理中的采用
2. FDA Oversight of Laboratory-Developed Tests: Is It Necessary, and How Would It Impact Clinical Laboratories? [J] . Debra G.B. Leonard, Edward R. Ashwood, Michael C. Burgess, Clinical Chemistry: Journal of the American Association for Clinical Chemists . 2013 ,第7期

机译：FDA对实验室开发的测试的监督：这是必要的，它将如何影响临床实验室？
3. FDA oversight of laboratory-developed tests: Is it necessary, and how would it impact clinical laboratories? [J] . ScottM.G., AshwoodE.R., AnnesleyT.M., Clinical Chemistry: Journal of the American Association for Clinical Chemists . 2013 ,第7期

机译：FDA监督实验室开发的测试：是否有必要，它会如何影响临床实验室？
4. The FDA Perspective on Pre-Clinical Testing for High Intensity Focused Ultrasound Devices [C] . Gerald R. Harris International Symposium on Therapeutic Ultrasound . 2006

机译：FDA对高强度聚焦超声装置的临床前测试的透视图
5. Utility of Non-Invasive Prenatal Testing in Routine Obstetric Care in New York State [D] . Boris, Caroline 2014

机译：非侵入性产前检查在纽约州常规产科护理中的效用
6. FDAs Draft Guidance on Laboratory-Developed Tests Increases Clinical and Economic Risk to Adoption of Pharmacogenetic Testing [O] . Kenneth D. Levy, Victoria M. Pratt, Todd C. Skaar, -1

机译：FDA关于实验室开发的测试的指导草案草案增加了采用药物遗传学测试的临床和经济风险
7. FDA’s Draft Guidance on Laboratory-Developed Tests Increases Clinical and Economic Risk to Adoption of Pharmacogenetic Testing [O] . Levy Kenneth D., Pratt Victoria M., Skaar Todd C., 2015

机译：FDA关于实验室开发的测试的指导草案草案增加了采用药物遗传学测试的临床和经济风险

FDA oversight of laboratory-developed tests will facilitate adoption of pharmacogenetic testing into routine clinical care

著录项

相似文献

相关主题

期刊订阅